1,3-dipropyl-8-cyclopentylxanthine has been researched along with Astrocytoma, Grade IV in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taliani, S | 1 |
| La Motta, C | 1 |
| Mugnaini, L | 1 |
| Simorini, F | 1 |
| Salerno, S | 1 |
| Marini, AM | 1 |
| Da Settimo, F | 1 |
| Cosconati, S | 1 |
| Cosimelli, B | 1 |
| Greco, G | 1 |
| Limongelli, V | 1 |
| Marinelli, L | 1 |
| Novellino, E | 1 |
| Ciampi, O | 1 |
| Daniele, S | 1 |
| Trincavelli, ML | 1 |
| Martini, C | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Novel N2-substituted pyrazolo[3,4-d]pyrimidine adenosine A3 receptor antagonists: inhibition of A3-mediated human glioblastoma cell proliferation.
Topics: Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; Antineoplastic Agents; B | 2010 |